374Water Inc. (formerly PowerVerde, Inc.) — Form 10-Q Summary
Business context and reporting period
The filing is for the quarterly period ended March 31, 2015, and identifies the registrant as PowerVerde, Inc. The company later became known as 374Water Inc. It is developing and commercializing clean-energy electric power generation systems, but its planned principal operations had not commenced. Reported revenue consisted entirely of licensing and royalty revenue unrelated to the planned principal business.
The filing states that the company has been unprofitable since inception and relies on licensing revenue, debt, and equity financing to fund operations. The financial statements are unaudited and include normal recurring adjustments.
Financial metrics
| Metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Royalty revenue | $154,887 | $40,154 |
| Research and development expense | $84,656 | $151,481 |
| General and administrative expense | $109,784 | $153,435 |
| Total operating expenses | $194,440 | $304,916 |
| Loss from operations | $(39,553) | $(264,762) |
| Interest expense | $(13,779) | $(21,188) |
| Net loss | $(53,332) | $(285,950) |
| Basic and diluted loss per share | $(0.00) | $(0.01) |
| Weighted-average shares | 31,750,106 | 13,000,046 |
Revenue increased approximately 286.0% year over year. The operating loss narrowed substantially, and the net loss decreased 81.4%.
| Balance-sheet metric | March 31, 2015 | December 31, 2014 |
|---|---|---|
| Cash and cash equivalents | $3,427 | $4,736 |
| Accounts receivable | $154,887 | $189,220 |
| Total current assets | $176,769 | $220,486 |
| Total assets | $225,269 | $327,822 |
| Total current liabilities | $89,509 | $141,906 |
| Notes payable to related parties | $377,411 | $374,235 |
| Total liabilities | $466,920 | $516,141 |
| Stockholders' deficiency | $(241,651) | $(188,319) |
Working capital surplus was $87,260 at March 31, 2015, compared with $78,580 at December 31, 2014. The company had a highly limited cash balance and negative stockholders' equity.
Cash flow, debt, and liquidity
| Cash flow metric | Q1 2015 | Q1 2014 |
|---|---|---|
| Cash used in operating activities | $(1,309) | $(237,349) |
| Cash used in investing activities | $0 | $(13,591) |
| Cash provided by financing activities | $0 | $240,000 |
| Net decrease in cash | $(1,309) | $(10,940) |
| Cash at period end | $3,427 | $37,366 |
Related-party notes payable had a face amount of $400,000, less an unamortized warrant-related discount of $22,589, and carried a 10% interest rate. The notes were due in one principal payment on December 31, 2016 and were collateralized by receivables under a license agreement. A separate related-party note was partially repaid in May 2015, with the remaining balance extended to July 2015.
Material changes, outlook, and risks
- Royalty revenue increased materially, but the company reported no product-sales revenue in either comparable quarter.
- Research and development expense declined 44.1%, primarily because the company was testing rather than building new generator systems.
- General and administrative expense declined 28.5%, mainly due to lower legal and employee-compensation costs.
- Intellectual property was fully amortized for balance-sheet purposes at March 31, 2015; quarterly amortization expense was $54,953.
- Management expected 2015 biotechnology intellectual-property revenue to approximate 2014 levels, but provided no assurance that this would occur.
- The company stated that it needed to promptly raise substantial additional capital. Management warned that failure to obtain funding could force the company to cease operations.
- The filing includes a going-concern uncertainty arising from recurring operating losses, negative historical operating cash flows, and uncertainty regarding additional financing.
- Outstanding potentially dilutive securities excluded from diluted share calculations included warrants exercisable for 5,086,000 shares and options for 2,750,000 shares.
- A prior employment-related legal proceeding had been settled and all settlement payments had been made; the filing reported no pending legal proceedings and no material changes to previously disclosed risk factors.
- Management concluded that disclosure controls and internal control over financial reporting were effective as of March 31, 2015. The filing did not include an auditor attestation because the company qualified for the applicable smaller-reporting-company exemption.
Investor verification priorities
- Verify the registrant-name history and corporate continuity between PowerVerde, Inc. and 374Water Inc.
- Confirm the collectibility and sustainability of the royalty and licensing revenue, which represented 100% of reported revenue.
- Assess current liquidity and subsequent financing activity given the reported cash balance of only $3,427 and the stated risk of ceasing operations without additional capital.
- Review the terms, maturity, collateral, and related-party nature of the outstanding notes payable.
- Evaluate progress toward commercialization of the clean-energy systems, since planned principal operations had not commenced as of the reporting date.
- Review subsequent filings for changes in going-concern status, equity issuance, debt restructuring, litigation, and intellectual-property value.